Clinical Trials Directory

Trials / Completed

CompletedNCT00784797

Misopristol Versus Pitocin for Second Trimester Abortion

Comparison Between Misopristol and Pitocin After Mifepristone Preparation for Second Trimeter Abortion

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
145 (actual)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Second trimester abortion can be done surgically or medically. Medical abortion with mifepristone and misopristol is one of the common protocol, but misopristol have high rate side effect. The investigators recent study proved the efficacy of pitocin after mifepristone in second trimester abortion with minimal side effects. Working hypothesis and aims: To compare misopristol and pitocin after mifepristone preparation in second trimester in seccess rate, interval to abortion, side effects and patient satisfaction.

Conditions

Interventions

TypeNameDescription
DRUGmifepristone and misopristol200 mg mifepristone and after 48 hours vaginal misopristol 800 mgr followed by oral misopristol 400 mgr every 3 hours for maxamum 5 doses
DRUGmifepristone and oxytocin200 mg mifepristone followed 48 hours with high dose oxytocin drip (9 unit per hour)

Timeline

Start date
2009-01-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2008-11-04
Last updated
2013-11-21

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00784797. Inclusion in this directory is not an endorsement.